OptimizeRx Corporation (OPRX) Stock Overview
Explore OptimizeRx Corporation’s financial performance, market position, analyst ratings, and future outlook.
OptimizeRx Corporation (OPRX)
Key Financials
Key Financials
Market Cap
95.9M
P/E Ratio
13.97
EPS (TTM)
$0.36
ROE
0.05%
OPRX Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of OptimizeRx Corporation (OPRX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 42.73, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $14.94.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 13.97 and a market capitalization of 95.9M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.